25th October 2019
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs notes the recent share price movement and press reports. Download News25th October 2019
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs notes the recent share price movement and press reports. Download News